Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > New Deal for Adstiladrin
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(817)
•••
Comment by Oilminerdeluxeon Aug 27, 2023 4:22pm
211 Views
Post# 35607383

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Deal for Adstiladrin

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Deal for Adstiladrin Let's see what the next update says before keelhauling is in order. Bound to be some info of worth. Small stuff can be nice too. Safe to say, they don't want to make any mistake when applying and makeing their case. They must have advisors, whose recommendations they follow. Yes, we want more transparency but this is as vital of a time as it gets. Not sure they should provide anything more than absolutely needed. I am sure there will be many questions after the Q report, but let's wait for that one first. I would be a bit irritated if they don't mention anything about the BTD status, but will be happy with what little scraps they hopefully mention about it. Others might of course have a different opinion.
I hope we will know when the recent PP money runs out. Get the next financing over.

Here's to an exciting week. You never know. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities